gd T cells function in innate and adaptive immunity and are primed for secondary responses by procyanidin components of unripe apple peel (APP). In this study, we investigate the effects of APP and purified procyanidins on gd T-cell gene expression. A microarray analysis was performed on bovine gd T cells treated with APP; increases in transcripts encoding granulocytemonocyte colony stimulating factor (GM-CSF), IL-8 and IL-17, but not markers of TCR stimulation such as IFNg, were observed. Key responses were confirmed in human, mouse and bovine cells by reverse transcription-PCR and/or ELISA, indicating a conserved response to procyanidins. In vivo relevance of the cytokine response was shown in mice following intraperitoneal injection of APP, which induced production of CXCL1/KC and resulted in neutrophil influx to the blood and peritoneum. In the human T-cell line, MOLT-14, GM-CSF and IL-8 transcripts were increased and stabilized in cells treated with crude APP or purified procyanidins. The ERK1/2 MAPK pathway was activated in APP-treated cells, and necessary for transcript stabilization. Our data describe a unique gd T-cell inflammatory response during procyanidin treatment and suggest that transcript stability mechanisms could account, at least in part, for the priming phenotype.
Introduction
gd T cells are a class of lymphocytes involved in both the innate and adaptive arms of the immune system and thus possess numerous immune functions. 1 They are a unique T cell whose TCR (T-cell receptor) can recognize unprocessed, non-peptide antigens 2,3 and do not require antigen presentation by classical MHC molecules. 4 gd T cells can also process and present antigen as classic antigen presenting cells (APCs). 5, 6 They are found at many portals of entry into the body and thus are well positioned to respond immediately to infection and/or insult. They are a major source of immune cytokines early in many infections and can also perform direct cytotoxic functions. Our laboratory has recently described the ability of gd T cells from bovine and human to respond to a procyanidin component (specifically oligomeric procyanidins) from unripe apple peel (APP) in a manner called priming. [7] [8] [9] [10] A primed gd T cell expresses surface IL-2Ra and CD69 in addition to producing select inflammatory cytokines, but not the prototypic inflammatory cytokine, IFNg. 7 Furthermore, in the absence of a secondary stimulus, a primed gd T cell demonstrates limited proliferation. [8] [9] [10] This observation is particularly interesting with respect to the innate immune capacity of these cells, as this phenotype suggests that select dietary procyanidins prime gd T cells to be in a heightened state of responsiveness without fully activating them. In support of this, feeding mice with APP in their drinking water leads to expansion of the gd T-cell pool within the intestinal mucosa. 11 The mechanism by which procyanidin-induced priming of gd T cells and eventual expansion in vivo occurs has not been defined, but elaborating upon our understanding of these responses is important in understanding how immune responses could potentially be fine-tuned to benefit host immunity.
Procyanidins are members of the polyphenol group of metabolites unique to plants. They can be assembled into oligomers to result in a very diverse body of procyanidin species that function on both plant and mammalian systems, including antioxidant, anti-pathogen and anticancer activities, as well as immunostimulatory effects. 10 We have previously shown that oligomeric procyanidins from APP are active on both primary human gd T-cell populations, Vd2 and Vd1. 8 Additionally, a large subset of human natural killer cells and a small subset of ab T cells and B cells also respond to these agonists. Therefore, it is likely that procyanidins do not signal through the TCR but rather through a mechanism common to these cell types. 8 Larger oligomeric species, including trimer molecules, exhibit greater specificity towards gd T cells than other cell types. Of the commercially available purified procyanidins, procyanidin C1 (PC1), a trimer isolated from grape seed, had the most robust priming activity on human peripheral blood mononuclear cells (PBMCs), whereas smaller oligomers were less potent. 10 In bovine gd T cells, APP-derived procyanidins induce a priming phenomenon very similar to that observed by pathogen-associated molecular patterns (PAMPs), in which the rapid production of a select set of immune cytokines, such as granulocyte-monocyte colony stimulating factor (GM-CSF) and myeloid cell chemokines (IL-8), but not the prototypic gd T-cell cytokine IFNg, 7, 12 is observed. IL-8 is a chemokine, the primary role of which is to recruit neutrophils to sites of inflammation and/or infection, 13 whereas GM-CSF is a growth factor that exerts an effect on hematopoietic stem cells to generate granulocytes (including neutrophils, eosinophils and basophils) and monocytes. GM-CSF and IL-8 both contain similar adenosine/uridine-rich elements (AU-rich element (AURE-also referred to as an ARE; however, to avoid confusion with antioxidant response elements, which are also targeted by procyanidins 1 , the AURE nomenclature will be used herein)) 14, 15 found in the 3 0 UTR of many transcripts, the expression of which must be tightly regulated because of the inflammatory or oncogenic nature of the encoded protein. 16 AUREs are targeted by proteins appropriately named AURE-binding proteins (AURE-BP), and interaction of the element with an AURE-BP can either increase or decrease the stability of the transcript. 17 AUREs are classified into three distinct groups that differ both in their sequence, as well as in the mechanism of transcript degradation. 18 GM-CSF and IL-8, as well as many other immune-associated genes, contain class II AUREs, which are defined by their multiple overlapping copies of the 5 0 -AUUUA-3 0 motif. 14, 15 Gene expression of IL-8 and GM-CSF can also be controlled similarly, as transcription of both genes is regulated by the NFkB and MAPK pathways. [19] [20] [21] Because of such similarities, we hypothesized that the molecular details of the unique inflammatory profile in cells treated with APP procyanidins could rely on these post-transcriptional mechanisms.
In this study, we took advantage of three different model systems (mice, cattle and humans) to define conserved responses of gd T cells towards plant-derived procyanidins. Microarray analysis of sorted bovine gd T cells showed that a number of myeloid cell cytokines, including IL-8 and GM-CSF, were upregulated after APP treatment, confirming a PAMP-like gd T-cell priming response during procyanidin culture. Furthermore, mice injected intraperitoneally with APP displayed neutrophil influx and elevated CXCL1/KC (mouse equivalent of IL-8) levels in both the peritoneum and the blood, affirming the relevance of the expression of these cytokines in vivo. To test the impact of procyanidins on the stability of these AURE-containing transcripts, we used the human gd T-cell line, MOLT-14. Both IL-8 and GM-CSF were stabilized in cells treated with either APP or purified procyanidin (PC1), and this event likely occurred via the ERK1/2 MAPK pathway. Together, our data suggest that a transcript stabilization mechanism is activated in APP-treated cells and could account, at least in part, for the gd T-cell priming response, as transcript stabilization could enable the cell to rapidly produce large amounts of cytokines in preparation for secondary stimulation or insult.
Results

APP induces robust changes in global transcript levels in primary bovine gd T cells
To broaden our understanding of the transcriptome profile induced in gd T cells treated with APP beyond a few selected cytokines, a microarray experiment was performed using primary sorted bovine gd T cells. We used the advantage of the bovine system for these experiments as large numbers of gd T cells could be purified to near homogeneity from neonatal animals. 22 Importantly, the APP preparation used in these studies has been documented to contain 95% polyphenolic compounds, the majority of which are procyanidins, with undetectable or very little endotoxin. 8 Cells were treated with buffer carrier or APP for 4 h and then RNA was extracted and used to probe an Affymetrix Bovine Genechip array as described. 23 APP treatment of gd T cells significantly increased transcript levels for B2000 genes at least twofold while there were few genes significantly downregulated in the APP-versus phosphate-buffered saline (PBS)-treated gd T cells (see GEO series number GSE13321). The most robust response was observed for the GM-CSF transcript, which was induced B85-fold over PBS-treated cells ( Table 1) . Transcripts for activation markers such as CD69 and IL-2Ra were also induced over PBS-treated control cells. Other transcripts with increased expression included VEGF, an endothelial growth factor, and NK cell molecules including the killer cell lectin-like receptor 1, but the significance of their expression was not further analyzed. Interestingly, overt inflammation markers such as IFNg were not detected in these experiments. However, other inflammatory molecules such as tumor necrosis factor-a (TNFa) and IL-8 were induced 5.8-fold and 3.1-fold, respectively. This pattern of gene expression was consistent with gd T-cell priming 8, 9 and other work in our laboratory 7 where procyanidins induce a unique inflammatory profile in gd T cells that does not include expression of IFNg.
APP procyanidins prime mouse gd T cells in vitro and alter the mouse cytokine profile in vivo, resulting in neutrophil influx to the blood and peritoneum An increased gd T-cell population in the intestinal mucosa of mice 11 and rats. 24 is observed after consumption of APP, suggesting that a murine response occurs similar to that described for bovine and human gd T cells. [7] [8] [9] [10] As such, we wanted to determine whether mouse gd T cells similarly respond to APP in vitro. To test for a mouse response to oligomeric procyanidins, we used a commercially available, highly purified oligomeric trimer (PC1). Priming was quantified by the number of gd T cells that proliferated following APP and PC1 treatment compared with the un-primed (buffer control) culture. Procyanidin treatment induced gd T-cell proliferation in response to IL-2 (Figures 1a (BALB/C) and 1b (C57Bl/6)), indicating APP and purified procyanidins exerted an effect as gd T-cell priming agents in two common inbred mouse strains. Similar to previous experiments with bovine and human cells, a small percentage of non-gd T-cell lymphocytes proliferated. In human cultures, the non-gd T cells responding to procyanidin are predominantly NK cells, however this procyanidin-responsive population was not characterized in mice. 8 Next, we tested for the ability of mouse cells to increase expression of the prototypical priming transcripts encoding GM-CSF and IL-8. Spleen cell preparations from BALB/c mice were treated with buffer/carrier or APP for 4 h, and CXCL1/KC (IL-8 homolog), as well as GM-CSF, were measured by quantitative reverse transcription-PCR (RT-PCR). As shown in Figure 1c , both cytokine transcripts were readily detected following APP treatment. 10 As IL-8 and GM-CSF are expressed in procyanidin-treated cells from human (unpublished data) and bovine (Table 1 ) and were confirmed in mouse, we chose to focus the remainder of our studies on these two cytokines.
We next performed in vivo experiments to assess a functional role for procyanidin-induced CXCL1/KC and GM-CSF. As GM-CSF and CXCL1/KC induce the development of a peritonitis response, 25, 26 we chose this model to measure APP responses in vivo. Neutrophil influx was measured as the ratio of neutrophils (RB6-8C5 bright CD11b bright ) to total leukocytes (CD45.2 þ ).
Substantial neutrophil influxes were observed in both the blood (neutrophilia) and the peritoneum (recruitment) of mice injected with APP ( Figure 2a ). Administration of purified procyanidins likewise induced neutrophilia; as little as 50 mg PC1 induced significant neutrophil accumulation (data not shown). As shown in Figure 1 APP and/or purified procyanidin (PC1) prime mouse gd T cells to proliferate in response to IL-2 and induce CXCL1/KC and GM-CSF expression in murine splenocytes. (a) CFSE-labeled BALB/ c splenocytes were cultured in X-VIVO-15 medium with PBS or PC1 (15 mg ml À1 ) for 24 h. Culture supernatant fluid was then replaced with fresh medium containing 1 ng ml À1 rhIL-2 and cultured for an additional 72 h. Cells were then stained for gd TCR (GL3) and analyzed by flow cytometry. A representative example of a twocolor FACS plot from one of three experiment repeats is shown. Values represent the percent proliferated of either the gd T cell (top region) or non-gd T cell (bottom region) populations. Percent proliferation was measured by dividing the number CFSEdim cells (gated) from the number of total cells in the respective population. (b) Experiments performed as described in a were also completed using spleen cells from C57Bl/6 mice, and responses to APP and PC1 were compared. Data represent the average ± s.d. from three experiments (Po0.001 for both APP and PC1 vs buffer control). (c) Spleen cells isolated from BALB/c mice were treated with APP or PBS in X-VIVO for 4 h. RNA was extracted from each sample and subjected to quantitative RT-PCR for actin, GM-CSF and CXCL1/KC. Results represent mean ± s.d. from triplicate values. CD69 (early T-cell activation antigen) 6.7 CCR5 6.1
Chemokine (C-X-C motif) ligand 2 6.0 IL-1Ra 6.0 IL-2Ra 5.8 TNFa 5.8
Chemokine (C-X-C motif) ligand 16 5.7 Chemokine (C-C motif) ligand 20 5.4
MHC class I heavy chain
Abbreviations: CCR5, chemokine receptor 5; GM-CSF, granulocytemonocyte colony stimulating factor; ODC 1, ornithine decarboxylase 1; PBS, phophate-buffered saline; TGFb1, transforming growth factor beta 1; TNFa, tumor necrosis factor alpha; VE-JAM, vascular endothelial junction-associated molecule; VEGF, vascular endothelial growth factor Complete microarray data are accessible under GEO series number GSE13321. Figure 2b , B785 pg ml À1 CXCL1/KC was detected in the IP fluid wash, and 1400 pg ml À1 was detected in the blood of mice injected with APP, confirming that the neutrophil response observed in APP-injected mice correlates with the expression of CXCL1/KC. Likewise, neutrophil recruitment to the peritoneum was observed when CXCR2 À/À mice, which lack the major CXCL1/KC receptor, were used in the same procedure, thereby confirming a role for CXCL1/KC in this process ( Figure 2c ). GM-CSF was not detected by ELISA in the same sample fluids at the 4 h time point (unpublished data). It is possible that GM-CSF could be detected at time points different than those tested, but it is also possible that the ELISA method used here was not sensitive enough for this model. These gene and protein expression data and in vivo responses suggested that GM-CSF and CXCL1/KC have a key role in affecting the procyanidin response in vivo, and thus these transcripts were further analyzed.
GM-CSF and IL-8 transcripts are stabilized in human gd T cells during treatment with APP After validating that procyanidin effects in the mouse were similar to previous reports for other species 8 and demonstrating an in vivo relevance for procyanidins, we next sought to ascertain the mechanism for the rapid response to secondary stimuli after priming with APP. 8 In an effort to control for variability in primary cell cultures and the limited number of gd T cells available in such cultures, we selected a cell line. Several cell lines were tested for procyanidin responsiveness including: THP1, Monomac-1, Jurkat, Lucy, PEER and MOLT-14 cells (data not shown). Of those tested, only MOLT-14 cells, a gd TCR þ human leukemia cell line, upregulated GM-CSF and IL-8 transcripts, as well as, generated GM-CSF in response to procyanidin culture (Supplementary Figure 1 and data not shown). Thus, using the MOLT-14 cell line, we designed experiments to begin to define the mechanism by which GM-CSF and IL-8 transcript and protein are induced in cells treated with APP. On the basis of the rapid responses we previously observed in primed gd T cells, we hypothesized that these transcripts contain structural features enabling this rapid induction. 8 On analyzing the transcripts for similar structures, we observed that GM-CSF and IL-8 contain similar AUREs that function to modulate transcript degradation rates. 16 Therefore, the stability of these transcripts was analyzed following treatment with APP. MOLT-14 cells were treated with APP or TNFa for 4 h, and then with actinomycin D to prevent de novo transcription. RNA was harvested at time 0 (collected immediately before actinomycin-D treatment), 30 min, 90 min and 4 h post-actinomycin D treatment, and samples were analyzed by quantitative RT-PCR using 18S to determine relative expression. As MOLT-14 cells constitutively express very low GM-CSF and IL-8 (data not shown), treatment with TNFa was used as a negative control as it induces expression of GM-CSF transcript but does not stabilize it. 27 GM-CSF transcript at the time of collection (t ¼ 0) in TNFa-treated cells was B11.8-fold less than in APP-treated cells, and 2.1-fold greater than in PC1-treated cells. Initial IL-8 transcript was similar in APP-and TNFa-treated cells (1.4-fold greater than TNFainduced transcript). In APP-treated cells, GM-CSF decreased to 49% of the initial amount 30 min after actinomycin-D-induced transcription blockade, and remained at 48 and 17% of the initial amount after 90 min and 4 h, respectively ( Figure 3a ). By comparison, the transcript was degraded quickly in TNFa-treated cells; GM-CSF transcripts decreased to 20% of the initial amount at 30 min, and were nearly equivalent to PBStreated cells at both 90 min and 4 h following TNFainduced induction. These results indicate that APP-but not TNFa-induced GM-CSF were likely stabilized in MOLT-14 cells. We also tested whether the purified PC1 trimer also influenced the stability of GM-CSF in MOLT-14 cells. As shown in Figure 3b , PC1 both induced and stabilized the GM-CSF transcript. Although the induced expression of GM-CSF by PC1 was not as robust as that induced by APP (t ¼ 0 was 22-fold less than with APP), treatment with PC1 resulted in a stability pattern similar to that for APP. These data confirm that defined procyanidin species, such as the PC1 trimer, induce transcript stability in gd T cells.
We then performed similar experiments using the IL-8 transcript. As shown in Figure 3c , IL-8 was similarly regulated by APP and TNFa, although induced IL-8 levels were less when compared with GM-CSF (4-fold increase versus background vs 919.7-fold increase for GM-CSF). TNFa-induced IL-8 expression was not stabilized and was equivalent to cells treated with PBS by 90 min. In comparison, treatment with APP resulted in IL-8 stabilization, which remained significantly greater than background (PBS), even after 4 h.
Previous reports demonstrate predicted half-lives for GM-CSF and IL-8 to be B30 28 and 20min, 29 respectively. Therefore, we predicted un-stabilized transcripts would be greatly diminished at 90 min (3 half-lives for GM-CSF and 4.5 half-lives for IL-8), and in fact this was observed in these experiments, with the greatest difference in transcript retention between APP-and TNFa-treated cells being observed 90 min after transcription was inhibited via actinomycin D. As the greatest change in transcript stability was observed 90 min after transcript blockade, we chose this time point while validating our methods.
We performed three additional experiments to address potential artifact in these transcript stability experiments. First, to address the potential that the observed transcript stabilization was an artifact of the MOLT14 cell line, we tested primary cultures for increased stabilization in APP-treated cultures. Bovine PBMC cultures were selected because they contain a higher percentage of responding cells than human or mouse PBMCs. As shown in Figure 3d , primary PBMC cultures treated with APP had more stable GM-CSF transcripts than TNFatreated cultures. This demonstrated that the transcript stabilization in MOLT14 cells was not an artifact of the cell line. Second, to control for artifact due to actinomycin D in the t ¼ 30, 90 and 240, but not t ¼ 0 RNA preparations, we added actinomycin D to all samples, including t ¼ 0, before collection. Similar to previous experiments (Figures 3a and c) , we observed rapid degradation in TNFa-, but not APP-treated cultures ( Supplementary Figure 2A) . Finally, as procyanidins bind with high avidity to proteins and other compounds, 10 we questioned whether the observed transcripts could be a result of APP-induced actinomycin-D precipitation and thereby incomplete blockade of transcription. To address this potential artifact, we tested whether removal of APP at the point of actinomycin-D treatment had an effect on transcript maintenance. To this end, we treated bovine PBMCs with APP for 4 h, washed twice with medium to remove free procyanidin, and added fresh medium containing actinomycin D with either APP or PBS. At 90 min after the fresh media were added, RNA was collected from the cells and GM-CSF transcripts were assayed by RT-PCR. As expected, because of the outbred nature of calves, as well as varying ages of individuals, there were differences in GM-CSF levels from animal to animal. However, there was no difference in transcript levels when actinomycin D was incubated in the presence or absence of APP (Supplementary Figure 2B) , thereby indicating APP did not affect actinomycin-D activity.
The ERK1/2 pathway is activated in MOLT-14 cells treated with APP We next performed experiments to identify the pathway(s) that could be responsible for the transcript stabilization observed in cells treated with procyanidins. We began by investigating the possible activation of a MAPK pathway, as signaling through these modules is important in transcript stability. [30] [31] [32] [33] MOLT-14 cells were treated with PBS or APP for 30 m, 60 m or 4 h, whereupon cell lysates were prepared and subjected to SDS-PAGE and western immunoblot using antibodies specific for phosphorylated ERK1/2 (p44/p42), p38, as well as JNK MAP kinases. Blots were subsequently stripped and re-probed using antibodies specific for the unphosphorylated form of the corresponding protein to verify equal loading between lanes. As shown in Figure 4a , the ERK1/2 molecules were phosphorylated to high levels in cells treated with APP, but not in those treated with PBS alone. p38 MAPK was not phosphorylated in response to APP, whereas APP did result in the phosphorylation of JNK1 and JNK2 ( Supplementary Figure 3 ), suggesting activation of the JNK/SAPK MAPK pathway.
The ERK1/2 MAPK pathway is involved in GM-CSF and IL-8 transcript stabilization in MOLT-14 cells treated with APP As the ERK and p38 pathways have been reported to stabilize AURE-containing transcripts, and the p38 Cell lysates were prepared and subjected to western immunoblot for phospho-ERK1/2 or total ERK1/2. Data are representative of three independent experiments. (b) Cells were treated with APP, APP and 20 mM U0126, or mock and harvested at 15, 30, 60, and 240 min. Cells were then lysed and analyzed for phospho-ERK1/2 or ERK1/2 via western blot. (c) MOLT-14 cells were treated with PBS or APP in cRPMI for 2 h, followed by treatment with U0126 for 2 h, and then with actinomycin D for the time indicated in the figure. RNA was extracted from each sample and subjected to quantitative RT-PCR for 18S, GM-CSF and IL-8. Data represent mean of triplicate values±s.d. and are presented as the normalized amount of each transcript to 18S. The percentage of each transcript that remained following treatment was calculated after subtracting background (PBS t ¼ 90 min). Data are representative of three independent experiments.
Transcript stability in cd T cells KF Daughenbaugh et al pathway was shown to not be activated during procyanidin culture, we next tested whether the ERK1/2 MAPK pathway has a role in the increased stability of GM-CSF and IL-8 in APP-treated MOLT-14 cells. To this end, we used an ERK1/2 inhibitor in stability experiments. U0126 inhibits MEK1/2, the upstream kinase of ERK1/2, and thus inhibits any signaling events downstream of ERK1/2 phosphorylation. 34 In these experiments, MOLT-14 cells were treated with APP for 2 h to induce gene transcription, and then with 20 mM U0126 for an additional 2 h. This treatment condition was determined to inhibit ERK1/2 phosphorylation in MOLT-14 cells by western immunoblot (Figure 4b ). Cultures stimulated for 4 h as above with PBS, APP or APP/ U0126 were then treated with actinomycin D, and RNA samples were harvested at 0 , 30 and 90 min. As shown in Figure 4c , treatment with APP induced stability of GM-CSF as previously seen, but treatment with U0126 before actinomycin-D treatment abolished this effect (presence of the transcript was reduced to 14% of the initial total by 30 min and to 7% by 90 min in the presence of U0126, compared with 60% and 31%, respectively, when cells were treated with APP alone). A similar observation was made for the IL-8 transcript in cells pretreated with U0126, where its presence was reduced to 54 and 39% of the initial concentration after 30 and 90 min of actinomycin-D exposure, respectively. In contrast, APP-treated cells not treated with U0126 retained 89 and 73% of IL-8 after 30 and 90 min, respectively (Figure 4c ). These data suggest that the ERK1/2 pathway is at least partially responsible for the induced stability of these transcripts.
We next tested the ability of U0126 to regulate the decay rate of c-jun, a quickly degraded (half-life of B20 min 35 ) transcript containing a class III AURE (as opposed to the class II AURE from IL-8 and GM-CSF). MOLT-14 cells were treated with APP for 2 h, then with the U0126 inhibitor for 2 h, followed by treatment with actinomycin D. RNA was harvested at 0, 30 and 90 min post-actinomycin-D treatment, and RT-PCR was performed as previously described. As shown in Figure 5 , c-jun transcript expression was induced in cells treated with APP at time 0, as expected. The presence of the c-jun transcript decreased over time in cells treated with APP. When cells were pre-treated with the U0126 inhibitor before actinomycin-D treatment, the decay rate of the c-jun transcript was not accelerated. In fact, treatment with the inhibitor potentially stimulated transcript production despite the presence of actinomycin D. Importantly, this observation is distinct from what was observed for both the GM-CSF and IL-8 transcripts, and suggests that APP-induced ERK1/2 activation is specific for these class II AURE-containing transcripts. Together, these data suggest that transcript stabilization may be a mechanism for gd T-cell priming in response to procyanidins.
Discussion
This report begins to define the mechanisms that are involved in our previous reports of procyanidin-induced gd T-cell priming. Many transcripts associated with inflammation, including IL-8 and GM-CSF, were found to be increased in expression upon procyanidin stimulation. However, the effect on gd T cells is unlike TCR stimulation in that IFNg transcript levels are unchanged. 7 We show in vivo relevance for the procyanidin-induced cytokine response with the observation that injection of APP results in a rapid neutrophil influx into both the peritoneum and blood. Furthermore, these studies show that GM-CSF and IL-8 are stabilized in cells treated with procyanidins and this likely occurs via ERK1/2 MAPK signaling. Together, these data describe a mechanism where cytokines involved in the generation and recruitment of neutrophils are induced and stabilized by APP procyanidins. The microarray analyses performed on gd T cells indicate that these responses are similar to PAMP-induced gd T-cell priming. 8 These PAMP responses are characterized as mild inflammatory responses, leading to increased responses upon secondary stimulation. This may prove a useful alternative to PAMP agonists currently being tested in clinical applications as these candidates have undesired side effects.
These microarray results also confirmed our previous reports 7 that GM-CSF is dramatically upregulated during APP treatment (85.2-fold increase). When tested in mice, procyanidins, including purified PC1, elicited similar responses to those defined in humans and cattle. As oral delivery increases gd T-cell populations in the gut, 11 our confirmation of a mouse response is not surprising, however, characterization of a phenotype in these different tissues demonstrates that the effect of procyanidins is not limited to the intestinal mucosa. Furthermore, using this peritonitis model, we were also able to confirm the importance of the secreted cytokine CXCL1/KC (functional equivalent to IL-8). MOLT-14 cells were treated with PBS or APP in cRPMI for 2 h, followed by treatment with U0126 for 2 h, and then with actinomycin D for the time indicated in the figure. RNA was extracted from each sample and subjected to quantitative RT-PCR for 18S and c-jun. Data represent mean of triplicate values±s.d. and are presented as the normalized amount of each transcript to 18S. The percentage of each transcript that remained following treatment was calculated after subtracting background (PBS t ¼ 90 min). Data are representative of three independent experiments.
Using CXCL1/KC (IL-8) and GM-CSF as key cytokines in the procyanidin response, we looked for a mechanism that could explain the gd T-cell priming response. Both of these transcripts contain an AURE in their 3 0 UTR, 14, 15 which suggested that the presence of these elements have a role in the reduced degradation rate of these mRNAs in APP-treated MOLT-14 cells. These studies demonstrated that both the GM-CSF and IL-8 transcripts were stabilized in cells treated with APP. AURE-containing transcript degradation is often regulated and associated with p38 and/or ERK1/2 MAPK activation. These results indicate that ERK1/2, but not p38 activity is important for the increased half-life of the GM-CSF and IL-8 transcripts in APP-treated MOLT-14 cells. This finding is uncommon, but has previously been described in the context of transcript stability. 17 Conversely, the p38 MAPK pathway is commonly implicated in stabilizing transcripts in other systems, 29, 31, 32, 36 but APP-mediated transcript stability seems independent of the p38 kinase, as its phosphorylation was not observed (data not shown). Perhaps the fact that the p38 MAPK pathway is not activated in APP-treated cells and is instead regulated by the ERK1/2 MAPK accounts for the unique inflammatory phenotype we detect. This conclusion is supported by previous studies that observe p38 MAPK activation in response to cellular stress, while the ERK1/ 2 MAPK module primarily responds to mitogenic stimuli. [37] [38] [39] [40] Previously, we found that APP enhanced gd T-cell proliferation in response to either IL-2 or IL-15 (see ref. 8) . Selective activation of the ERK1/2 MAPK pathway is consistent with these observations. Likewise, activation of the ERK1/2 MAPK pathway results in an anti-inflammatory cellular environment 41 and could explain why, even in the face of robust induction of some inflammatory cytokines, expression of the prototypic inflammatory cytokines of gd T cells, such as IFNg, is not seen. Investigation into the role of the JNK MAPK pathway in APP-treated MOLT-14 cells will also shed light on APP-mediated mechanisms, as the JNK module, like p38, signals in response to events such as inflammation and apoptosis. [42] [43] [44] Although it is not clear how MAP kinases regulate AURE degradation, studies have revealed that they can both phosphorylate and regulate the activity of at least some AURE-binding proteins. There are many immunologically relevant AURE-BPs that can affect transcript stability and can have opposing roles in transcript degradation on the basis of the presence, absence or phosphorylation state of these proteins. Commonly described AURE-BPs include the following: TTP, BRF1, BRF2, Roquin and CUGBP1, which promote transcript degradation, HuR, NF90, YB-1 and AUF2, which prevent degradation, and AUF1 and KSRP, which can either induce or prevent transcript degradation. Many of these AURE-BPs have been shown to regulate GM-CSF and/or IL-8 (CXCL1/KC) transcript stability including AUBF, 45 YB-1, 46 TTP, 15, 47 HuR 48 and KSRP. 15 As GM-CSF, IL-8 and CXCL1/KC contain Class II AUREs, 14, 15, 49, 50 it is possible that regulation of their decay is related to the activity of a common protein. Further experiments are underway to fully understand MAP kinase activity and AURE-BP interactions during procyanidin treatment.
These studies shed some light on the apparent dichotomy existing with respect to the function of procyanidin molecules. Procyanidins are proposed for the treatment of inflammatory diseases, 51 as well as in the clearance of infection, 52, 53 indicating that they have both anti-inflammatory and pro-inflammatory properties. For example, some procyanidins can inhibit NFkB activity [54] [55] [56] [57] [58] [59] and have a role in inhibiting the development of food allergies 11 and allergic rhinitis. 60 Likewise, procyanidins from grape seeds have anti-tumor activity. 61 In contrast, procyanidins from cocoa have a pro-inflammatory effect on PBMCs by inducing cytokine release. 62 Our data point to an inflammatory phenotype for gd T cells treated with APP, as evidenced by the nature of the induced cytokines such as GM-CSF and IL-8. However, it is clearly a restricted phenotype in that overt activation markers, such as IFNg, are not induced, and activation of the ERK1/2 and JNK1/2 MAPK pathways but not p38 is detected. Perhaps this limited inflammatory response contributes to downstream regulatory responses that ultimately dampen or control expression of other inflammatory molecules. Alternatively, it seems other AURE-containing transcripts could be stabilized during procyanidin treatment. If this were to occur, it would stand to reason that the production of these cytokines, should the cell be producing them, would similarly increase. This could lead to an improvement in the response, should it be inflammatory or suppressive. Clearly, these questions remain to be answered, however, the demonstration that mice respond to procyanidins will provide an accessible model system to test these hypotheses under both inflammatory and infectious conditions. Collectively, the data reported herein divulge a mechanism by which APP rapidly and robustly induces a unique response in vitro and in vivo. Importantly, we have begun to define a cross-species mechanism by which gd T cells, thought to be a bridge between the innate and adaptive immune systems, are primed in response to APP. Our model predicts that this priming response could enhance either pro-inflammatory or immunoregulatory activities of gd T cells, which would be dictated by the nature of a secondary stimulus. Although we are focused on gd T cells, these mechanisms could also be involved in procyanidin effects on other lymphocytes, such as NK cells and subsets of ab T cells that also respond, as shown in our earlier study. 8 Further defining these mechanisms and their impact in vivo will provide insight into optimizing the use of these types of compounds to treat inflammatory diseases, 51 as well as enhancing the clearance of various infections. 52, 53 
Materials and methods
Cell culture MOLT-14 cells (DSMZ, Brunswick, Germany) were maintained at a density of approximately 1.5 Â 10 6 cells ml À1 in complete RPMI (Cellgro, Manassas, VA, USA) containing 10% fetal bovine serum 63 (Hyclone, Waltham, MA, USA) at 37 1C and 10% CO 2 . At 24 h before any experiment, cells were collected by brief centrifugation at 500 g, then suspended at 1.5 Â 10 6 cells ml À1 in serum-free medium, X-VIVO-15 (X-VIVO; BioWhittaker, Walkersville, MD, USA), in 6-or 12-well tissue culture plates (BD Falcon; Becton Dickinson, Franklin Lakes, NJ, USA), depending on the experiment. Primary bovine PBLs were obtained as previously described. 8 Briefly, freshly collected PBMCs were prepared by Histopaque 1077 (Sigma-Aldrich, St Louis, MO, USA) density gradient and monocytes were removed using anti-CD14 microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany). Monocyte depletion was confirmed by fluorescenceactivated cell sorting (FACS) (FACSCalibur, BD Biosciences, San Jose, CA, USA). For transcript stabilization studies, cells in X-VIVO were treated with APP (Apple Poly, Littleton, CO, USA) at 54 mg ml À1 , recombinant human TNFa (PeproTech, Rocky Hill, NJ, USA) at 50 ng ml À1 , recombinant bovine TNFa (Thermo Scientific, Waltham, MA, USA), PC1 (Phytolab, Vestenbergsgreuth, Germany) at 50 mg ml À1 or PBS for 4 h, then with actinomycin D (Sigma-Aldrich) at 5 mg ml À1 . At the time-points indicated in the figures, cells were harvested from the wells and transferred to centrifuge tubes, then collected by centrifugation for 5 min at 500 Â g. Supernatant fluids were removed and discarded, and then RNA was extracted from the cell pellets using the Qiagen RNeasy kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. For studies using the U0126 inhibitor, cells in X-VIVO were treated with PBS or APP at 54 mg ml À1 for 2 h, then U0126 (Cell Signaling, Danvers, MA, USA) at 20 mM was added and cells were incubated for an additional 2 h, followed by treatment with actinomycin D as described above. For splenocyte culture, spleens were removed from WT (C57BL/6) or gd T-cell-deficient animals and were disrupted with ten strokes of a Dounce homogenizer in 10 ml X-VIVO medium. Suspensions were poured through a 70-mm filter to remove clumped cells and were plated in 12-well plates at a density of 2 Â 10 6 cells ml À1 in X-VIVO.
Mouse splenocyte priming assays
Carboxyfluorescein succinimidyl ester (CFSE)-labeled BALB/c splenocytes were prepared as above and cultured in X-VIVO medium with PBS or PC1 (15 mg ml À1 ) for 24 h. Culture supernatant fluid was then replaced with fresh medium containing 1 ng ml À1 rhIL-2 and cultured for an additional 72 h. Cells were then stained for gd TCR (GL3) and analyzed by FACS.
Microarrays
Microarray experiments were performed as previously described. 23, 64 Bovine PBMCs were collected from two different calves and gd T cells were stained with GD3.8 (pan gd T cell mAb) and sorted using a FACS Vantage (Becton Dickson) to purities greater than 97%. Sorted cells were rested overnight in X-VIVO and then stimulated with either PBS or APP (70 mg ml À1 ) for 4 h. RNA was extracted and analyzed on an Agilent Bioanalyzer (Agilent Technologies, Wilmington, DE, USA) to assess integrity. RNA was then amplified and used to probe Genechip Bovine Genome Arrays (Affymetrix, Santa Clara, CA, USA). Identical experiments were performed using cells from two different calves (four total arrays). The intensity of each gene on the APP array was normalized to its corresponding spot on the PBS array for each specific calf. Only genes determined to be present in all four arrays using the Gene Chip Operating Software program (Affymetrix) were used for further analysis. The fold change in gene expression over PBS from each calf was then averaged, and those with a threefold or greater increase after treatment with APP were included in the analysis in Table 1 . Microarray data were submitted to GEO and is accessible using the series number GSE13321.
Real-time RT-PCR
RNA was used in reverse-transcription reactions using random hexamer primers and SuperScript III enzyme (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. The resulting cDNA was used in quantitative PCR experiments using SYBR green reagent (Applied Biosystems, Foster City, CA, USA) and primers specific for 18S (forward: 5 0 -TCGAGGCCCTGTA ATTGGAAT-3 0 and reverse: 5 0 -CCCAAGATCCAACTAC GAGCTT-3 0 ), GM-CSF (forward: 5 0 -GCAGCCTCACCAA GCTCAAG-3 0 and reverse: 5 0 -TCTTTGCACAGGAAGT TT-3 0 ), IL-8 (forward: 5 0 -TTCAGAGACAGCAGAGCAC ACA-3 0 and reverse: 5 0 -GGCCAGCTTGGAAGTCATG T-3 0 ), beta-actin (forward: 5 0 -AAGGATTCCTATGTGGGC GA-3 0 and reverse: 5 0 -TCCATGTCGTCCCAGTTGGT-3 0 ) and c-jun (forward: 5 0 -CAGAGTCCCGGAGCGAACT-3 0 and reverse: 5 0 -CCTTCTTCTCTTGCGTGGCT-3 0 ). For mouse experiments the primers used were specific for beta-actin (forward: 5 0 -CCTAAGGCCAACCGTGAAAA-3 0 and reverse: 5 0 -GAGGCATACAGGGACAGCACA-3 0 ), GM-CSF (forward: 5 0 -GGTTCAGGGCTTCTTTGATGG-3 0 and reverse: 5 0 -CCTGGGCATTGTGGTCTACAG-3 0 ) and for CXCL1/KC (forward: 5 0 -TGCTAGTAGAAGGGTGTT GTGCGA-3 0 and reverse: 5 0 -TCCCACACATGTCCTCAC CCTAAT-3 0 ). Reactions were performed on a 7500 Fast Real-time PCR System (Applied Biosystems) in triplicate, and data were normalized to 18S or beta-actin to obtain relative transcript levels. Each individual experiment was performed a minimum of three times, and data are presented as average ± s.d.
ELISA analyses CXCL1/KC protein was detected in the blood and IP fluid of mice immunized with APP using the Quantikine KC Immunoassay kit (R & D Systems, Minneapolis, MN, USA). IL-8 was detected in supernatant fluids from MOLT-14 cells treated with APP using the Quantikine IL-8 Immunoassay kit (R&D Systems). GM-CSF was detected in supernatant fluids of MOLT-14 cells treated with APP using the GM-CSF ELISAMax kit (BioLegend, San Diego, CA, USA). All experiments were performed in triplicate according to the respective manufacturer's instructions. Data are presented as average ± s.d.
Peritonitis studies BALB/c or CXCR2 KO (gift of A Harmsen, Montana
State University) mice were injected in the peritoneum with APP (1 mg in PBS, optimal dose and timing were empirically determined) or different doses of purified procyanidins, and after 3 h blood was collected into blood collection Microvette 200 tubes (Sarstedt, Newton, NC, USA) with sera separated by centrifugation at 12 000 Â g for 10 min. Red blood cells were lysed in ACK buffer (0.15 M NH 4 Cl, 1 mM KHCO 3 , 0.1 mM EDTA), washed in Hank's Buffered Saline Solution (HBSS, Cellgro), and leukocytes were analyzed by flow cytometry as described below. After euthanasia, peritoneal cavities were washed with 300 ml HBSS (injected and retrieved) followed by a 5 ml wash with HBSS. Retrieved HBSS from the 300 ml wash was used for CXCL1/KC ELISAs. Cells from the 5 ml wash were collected by centrifugation at 500 Â g for 5 min and similarly sub-jected to flow-cytometric analysis. Blood and peritoneal cells were stained with directly conjugated RB6-8C5-FITC (anti-granulocyte receptor-1; Bright on all neutrophils), anti-CD45.2-APC (all leukocytes; disregards RBCs) and anti-CD11b-PE (bright on neutrophils) and read on a FACS-Calibur equipped with an HTS loader (BD Biosciences). Viable leukocytes were gated based on FSC/SSC and positive CD45 staining. Of the viable leukocytes, the percentage of neutrophils (RB6-8C5 bright /CD11b bright and distinctive light scatter profile) was determined. All animal procedures were performed in accordance with National Institutes of Health guidelines and approved by the Institutional Animal Care and Use Committee of Montana State University (Bozeman, MT, USA).
Western immunoblots
MOLT-14 cells were treated with PBS or APP for 30 m, 60 m, and 4 h at the concentrations described above. At the indicated time-points, cells were transferred to tubes and collected by centrifugation for 5 min at 500 g. Supernatant fluids were removed and discarded and pellets were suspended in buffer containing 0.15 M NaCl, 1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS and 10 mM Tris-HCl pH 7.2, and were incubated on ice for 30 min. Samples were boiled for 5 min before resolution on a 10% sodium dodecyl sulfate-PAGE gel. Proteins in the gels were transferred to nitrocellulose then blocked in 10% Blotto (10% w/v non-fat dry milk in PBS) for 1 h at room temperature. Blots were incubated with the following antibodies diluted 1:1000 in 0.5% Blotto at room temperature overnight: anti-phospho ERK 1/2 MAPK (Thr202/Tyr204)(Cell Signaling, Danvers, MA, USA), anti-phospho p38 MAPK (Thr180/Tyr182) (Cell Signaling), anti-phospho JNK1/JNK2 MAPK (Thr183/ Tyr185) (Abcam, Cambridge, MA, USA), anti-ERK1/2 MAPK (Cell Signaling), anti-p38 MAPK (Cell Signaling) or anti-JNK1/JNK2 MAPK (also known as SAPK/JNK) (Cell Signaling). Blots were washed three times with 0.5% Blotto and incubated with HRP-goat anti-rabbit secondary antibody at 1:5000 in 0.5% blotto for 2 h at room temperature. Blots were washed and developed with ECL reagent (GE Healthcare, Piscataway, NJ, USA) and exposed to film for autoradiography.
